ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

SNSE Sensei Biotherapeutics Inc

1.80
-0.01 (-0.55%)
최종 업데이트: 00:46:27
15분 지연
기업명 주식 심볼 시장 주식 타입
Sensei Biotherapeutics Inc SNSE 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.01 -0.55% 1.80 00:46:27
개장가 저가 고가 종가 전일 종가
1.80 1.71 1.85 1.81
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
06/03/202406:44EDGAR2Form 8-K - Current report
28/02/202421:31EDGAR2Form 8-K - Current report
17/02/202408:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202408:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202408:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/02/202406:31EDGAR2Form 8-K - Current report
04/01/202422:14EDGAR2Form 8-K - Current report
08/11/202306:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202321:35EDGAR2Form 8-K - Current report
07/11/202321:30GLOBESensei Biotherapeutics Reports Third Quarter 2023 Financial..
06/11/202320:07EDGAR2Form 8-K - Current report
04/11/202305:11EDGAR2Form 8-K - Current report
04/11/202305:05GLOBESensei Biotherapeutics Reports Favorable Clinical Data for..
03/11/202305:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202305:50EDGAR2Form 3 - Initial statement of beneficial ownership of..
01/11/202320:30GLOBESensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as..
25/10/202322:05GLOBESensei Biotherapeutics to Present Initial Clinical Data from..
23/10/202320:30GLOBESensei Biotherapeutics Presents Trial-in-Progress Poster for..
21/10/202306:01EDGAR2Form 8-K - Current report
27/09/202320:30GLOBESensei Biotherapeutics Announces Initiation of Combination..
21/09/202320:30GLOBESensei Biotherapeutics Presents New Preclinical Data..
13/09/202321:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/09/202320:30GLOBESensei Biotherapeutics to Present New Preclinical Data..
12/09/202306:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/09/202306:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/09/202306:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/09/202306:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/08/202320:30GLOBESensei Biotherapeutics to Participate in Upcoming Investor..
18/08/202306:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/08/202305:32EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/08/202321:45EDGAR2Form 8-K - Current report
03/08/202320:30GLOBESensei Biotherapeutics Reports Second Quarter 2023 Financial..
03/08/202306:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/08/202320:30GLOBESensei Biotherapeutics to Participate in Canaccord Genuity’s..
13/07/202305:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/07/202305:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/07/202305:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/07/202305:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/07/202305:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202305:31EDGAR2Form 8-K - Current report
01/06/202320:30GLOBESensei Biotherapeutics Announces First Patient Dosed in..
09/05/202320:30GLOBESensei Biotherapeutics Reports First Quarter 2023 Financial..

최근 히스토리

Delayed Upgrade Clock